Ah, the stock market. A bastion of logic, predictability, and calm, right? Not when former President Donald J. Trump is in the news. In a week that saw fresh rounds of tariff announcements, geopolitical saber-rattling, and a particularly pointed social media directive, one might expect Wall Street to be performing its usual impersonation of a fainting goat. Yet, as ever, the market’s reaction to the latest Trumpian pronouncements has been less a scream of terror and more a collective, albeit slightly bewildered, shrug.
The latest whirlwind of policy, delivered with the subtlety of a bullhorn at a library, arrived primarily via the digital town square known as Truth Social. It seems the traditional press conference is far too pedestrian for economic policy that promises to reshape global trade. This week’s highlights included a 100% tariff on pharmaceutical imports, new levies on furniture, and a rather specific call for a major tech company to fire one of its executives. All in a day’s work for the man who once famously declared trade wars “good and easy to win.”
Tariff Tsunami 2.0: The Pharma Edition (Now with Conditions!)
The pharmaceutical industry found itself squarely in the crosshairs with the announcement of a staggering 100% tariff on “any branded or patented Pharmaceutical Product” set to take effect on October 1, 2025. The stated rationale? A “feud with Tylenol” and a desire to boost domestic manufacturing. One might imagine pharmaceutical executives clutching their pearls, but the devil, as always, is in the details, or in this case, the escape clause. The tariff, it turns out, won’t apply if a company “IS BUILDING their Pharmaceutical Manufacturing Plant in America,” defined helpfully as “breaking ground” and/or “under construction”.
The market, ever the astute reader of fine print, seemed to take this conditional threat rather well. On Friday, September 27, shares of major drugmakers like Merck & Co. Inc., Eli Lilly and Co., and Johnson & Johnson all managed to eke out gains of less than 1% in midday trading, slightly outperforming the broader S&P 500 index. This rather serene response is largely due to these pharmaceutical giants having already announced U.S. expansion plans, effectively side-stepping the tariff bullet.
However, not everyone was so sanguine. Across the pond and in Asia, the initial shockwaves were more pronounced. European pharmaceutical firms like Lonza, Novartis, and Roche saw their shares dip around 1.2% in early trading, while Japanese counterparts such as Sumitomo Pharma closed 3.5% lower. The Pharmaceutical Research and Manufacturers of America (PhRMA) also chimed in with a warning that such tariffs could “affect investment in US pharmaceuticals”. Apparently, even a conditional 100% tax can make one a tad nervous. Meanwhile, Indian generic drug manufacturers, largely dealing in unbranded medicines, were expected to remain “largely unaffected” by the new tariffs, providing a small glimmer of stability in the global pharma supply chain.
Furniture Follies & Truck Triumphs: Tariffs for Your Sofa’s Security
Beyond the medicine cabinet, the latest tariff blitz extended its reach into the living room and kitchen. Upholstered furniture now faces a 30% tariff, while kitchen cabinets and bathroom vanities will be hit with a 50% levy, all effective October 1, 2025. The justification? “National Security” and protecting domestic manufacturing from the “large scale ‘FLOODING'” of these products. Because nothing says national defense quite like a locally sourced ottoman.
The impact here was a bit more direct, creating clear winners and losers. Import-reliant furniture retailers took a noticeable hit. RH (formerly Restoration Hardware) saw its stock fall 4.16% on Friday, September 27th, adding to a 7% plummet in after-hours trading on September 11th after its weak Q2 earnings report explicitly cited tariff impacts. Wayfair also dipped nearly 3% on Friday, with reports of drops between 5% and 8% in earlier premarket and after-hours trading. The National Retail Federation, ever the party pooper, warned that these tariffs would inevitably lead to “increased costs for consumers”.
Conversely, domestic manufacturers were popping champagne corks (or at least, enjoying a modest uptick). La-Z-Boy, for instance, saw its stock rise 8% on earlier tariff news, while other domestic players like Bassett Furniture, Ethan Allen Interiors, and Steelcase also saw positive movement.
In a slightly less aesthetically driven, but equally tariff-affected sector, heavy trucks also received a 25% import tax. This was good news for American truck manufacturer Paccar, the parent company of Peterbilt and Kenworth, whose stock surged 5.16% to $100.50 on Friday, September 27th, clearly benefiting from the protective measures. It seems that while your new sofa might cost more, at least the big rigs delivering it are proudly American-taxed.
Truth Social: The New SEC Filing?
In a testament to modern communication, or perhaps a subtle nod to the declining relevance of traditional media, many of these significant policy shifts were first broadcast via Truth Social. This platform also served as the venue for a rather direct instruction to a major tech company. On Friday, September 27th, Trump publicly demanded that Microsoft fire its Global Affairs President, Lisa Monaco, citing “national security concerns”. Monaco, having served in previous Democratic administrations, was deemed a “menace to U.S. National Security” by Trump, especially given Microsoft‘s extensive government contracts.
One might expect such a public declaration to send Microsoft shares into a tailspin. Yet, the tech giant, a behemoth in its own right, appeared largely unperturbed. Microsoft was noted as being “popular among investors this week,” with its stock price showing a positive movement of +0.87% on Friday, September 27th. Analysts, ever the optimists, maintained a “strong buy consensus” on MSFT, projecting a healthy 22.63% upside potential. It seems that even a presidential decree via social media struggles to derail a $4 trillion market cap company, though the potential for “volatility” was acknowledged.
The Broader Market’s Collective Shrug
Perhaps the most perplexing aspect of this week’s events was the overall market reaction. Despite the fresh wave of tariffs and the usual dose of political drama, the major U.S. indices largely finished higher on Friday, September 27, 2025. The Dow Jones Industrial Average (^DJI) settled 0.65% higher at 46,247.29, the S&P 500 (^GSPC) added 0.59% to finish at 6,643.70, and the tech-heavy Nasdaq Composite (^IXIC) increased 0.44% to settle at 22,484.07.
This somewhat counterintuitive rally, following a three-day slump, was attributed by analysts to “relief about inflation data” and a growing tendency for the market to “look through tariffs”. It seems investors are either developing a thick skin or have simply become accustomed to the unpredictable nature of trade policy announcements. While the daily performance was positive, it’s worth noting that all three benchmarks broke their winning streaks for the week, with the Dow down 0.2%, the S&P 500 slipping 0.3%, and the Nasdaq declining 0.7%. So, a short-term bounce, but the underlying uncertainty still gnawed away at weekly gains.
The market’s ability to digest, interpret, and often seemingly ignore the latest pronouncements from the former President remains a fascinating spectacle. Whether it’s the 100% tariff on patented pharmaceuticals (unless you’re building a factory, of course), or the sudden concern for the national security implications of imported bathroom vanities, the financial world continues to adapt with a blend of selective attention and weary resilience. As one analyst put it, “Rather than sparking a manufacturing renaissance, it’ll deter investment, heighten inflationary pressure and drive sophisticated capital to markets that remain open and predictable”. Or, perhaps, investors are simply waiting for the next Truth Social post to tell them what to think. Either way, it’s never a dull moment.
DISCLAIMER: We read Trump’s posts so you don’t have to. This is comedy meets market data, not financial advice. Not political advice either – we just like charts and chaos.
Elana Harper is a seasoned financial editor and market analyst with over a decade of experience covering global equities, economic trends, and corporate earnings. Known for her sharp insights, Elana specializes in making complex financial topics accessible to a broad audience. She now serves as the Senior Financial Editor at Stock Market Watch, where she oversees daily market coverage and political commentary.